Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial
M. Parellada, A. San José Cáceres, R. Delorme, A. Moscoso et autres
es, fr, gb, pl, us, nl (code pays fourni par la source)